title: Development of animal models underlining mechanistic connections between prostate inflammation and cancer.
abstract: The characterization of animal models has indicated that the genetic, dietary and environmental factors and hormonal imbalance may influence the risk to develop prostate inflammatory lesions and prostate cancer (PC) confirming human epidemiologic data. It is now established that the prostate inflammatory response typically results in major changes in the local microenvironment of epithelial cells of the prostate gland, including an intense stromal remodeling, activation of fibroblasts, infiltration of immune cells such as mast cells, macrophages and B and T lymphocytes and collagen deposition. The immune cells recruited at prostate inflammatory lesions and myofibroblasts may contribute to the release of numerous pro-inflammatory cytokines and chemokines that in turn can promote the oxidative stress, genomic instability and proliferation of epithelial cells. The accumulation of additional genetic and/or epigenetic alterations in prostatic stem/progenitor cells may subsequently culminate to their malignant transformation and PC initiation and progression and more particularly with advancing age. The potential mechanistic relationships between the molecular events associated with the persistent inflammatory response and prostate carcinogenesis have important implications for optimizing the current therapies against different prostatic disorders and PCs.
authors.affiliation: Murielle Mimeault, Surinder K Batra, Department of Biochemistry and Molecular Biology, College of Medicine, Eppley Cancer Institute, University of Nebraska Medical Center, Omaha, NE 68198-5870, United States.
authors.forename: Murielle
authors.initials: M
authors.lastname: Mimeault
authors.forename: Surinder K
authors.initials: SK
authors.lastname: Batra
keywords: Animal models; Prostate cancer; Prostate inflammation; Stromal remodeling; Therapies; Tumor microenvironment
references.citation: PLoS One. 2010 Oct 29;5(10):e13751
references.pmid: 21060787
references.citation: Cancer Res. 2002 Nov 1;62(21):6021-5
references.pmid: 12414622
references.citation: PLoS One. 2009 Sep 17;4(9):e7067
references.pmid: 19759906
references.citation: Clin Cancer Res. 2009 Nov 1;15(21):6658-64
references.pmid: 19843661
references.citation: J Urol. 1988 Nov;140(5):1049-53
references.pmid: 3172358
references.citation: Cancer Res. 2004 Sep 1;64(17):6137-43
references.pmid: 15342397
references.citation: Exp Gerontol. 2008 Nov;43(11):981-5
references.pmid: 18639623
references.citation: Am J Pathol. 2009 Sep;175(3):1187-99
references.pmid: 19700748
references.citation: Differentiation. 2007 Apr;75(4):325-36
references.pmid: 17286605
references.citation: Differentiation. 2002 Dec;70(9-10):473-85
references.pmid: 12492490
references.citation: Br J Cancer. 2013 Mar 19;108(5):1079-91
references.pmid: 23449353
references.citation: PLoS One. 2008;3(12):e3940
references.pmid: 19081794
references.citation: Neoplasia. 2010 Nov;12(11):915-27
references.pmid: 21076617
references.citation: Proc Natl Acad Sci U S A. 2009 Feb 17;106(7):2353-8
references.pmid: 19168635
references.citation: Neoplasia. 2006 Sep;8(9):708-15
references.pmid: 16984728
references.citation: Hum Gene Ther. 2012 Aug;23(8):871-82
references.pmid: 22551458
references.citation: Asian J Androl. 2012 Sep;14(5):745-51
references.pmid: 22705563
references.citation: Am J Prev Med. 2006 Feb;30(2 Suppl):S7-15
references.pmid: 16458793
references.citation: EMBO Mol Med. 2012 Aug;4(8):791-807
references.pmid: 22745041
references.citation: Oncogene. 2010 Mar 4;29(9):1293-302
references.pmid: 19946339
references.citation: PLoS One. 2010 Sep 23;5(9):e12920
references.pmid: 20886110
references.citation: CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29
references.pmid: 22237781
references.citation: Cancer. 1996 May 1;77(9):1862-72
references.pmid: 8646686
references.citation: Front Biosci. 2007 May 01;12:3273-86
references.pmid: 17485298
references.citation: Neoplasia. 2011 Aug;13(8):692-703
references.pmid: 21847361
references.citation: Eur Urol. 2013 Aug;64(2):177-88
references.pmid: 22939387
references.citation: Carcinogenesis. 2012 Oct;33(10):1965-75
references.pmid: 22791812
references.citation: Cancer Res. 2007 May 1;67(9):4244-53
references.pmid: 17483336
references.citation: Int J Androl. 2009 Aug;32(4):399-410
references.pmid: 19515173
references.citation: Clin Cancer Res. 2006 Jan 1;12(1):89-96
references.pmid: 16397029
references.citation: Prostate. 2009 Sep 15;69(13):1378-86
references.pmid: 19507201
references.citation: Am J Pathol. 2010 May;176(5):2259-68
references.pmid: 20363913
references.citation: Prostate. 2012 Jan;72(1):1-11
references.pmid: 21480312
references.citation: Am J Transl Res. 2012;4(2):165-74
references.pmid: 22611469
references.citation: Cancer Res. 1999 Oct 1;59(19):5002-11
references.pmid: 10519415
references.citation: Clin Exp Metastasis. 2013 Jan;30(1):13-23
references.pmid: 22678424
references.citation: Nature. 2005 Aug 4;436(7051):725-30
references.pmid: 16079851
references.citation: Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1480-5
references.pmid: 16432235
references.citation: PLoS One. 2012;7(8):e43833
references.pmid: 22952779
references.citation: N Engl J Med. 2004 Oct 7;351(15):1513-20
references.pmid: 15470214
references.citation: Nat Med. 2004 Jun;10(6):594-601
references.pmid: 15156201
references.citation: Mol Med. 2011 Sep-Oct;17(9-10):949-64
references.pmid: 21607288
references.citation: Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):711-6
references.pmid: 16614113
references.citation: J Steroid Biochem Mol Biol. 2004 Nov;92(4):221-36
references.pmid: 15663986
references.citation: Cancer Sci. 2003 Nov;94(11):974-9
references.pmid: 14611674
references.citation: J Urol. 2006 Aug;176(2):813-8
references.pmid: 16813953
references.citation: Nature. 2011 Feb 10;470(7333):269-73
references.pmid: 21289624
references.citation: PLoS One. 2011 Mar 04;6(3):e17449
references.pmid: 21394210
references.citation: Cancer. 2011 Mar 15;117(6):1123-35
references.pmid: 20960523
references.citation: Am J Pathol. 2011 Jul;179(1):502-12
references.pmid: 21703427
references.citation: Bone. 2012 Mar;50(3):695-703
references.pmid: 22173053
references.citation: N Engl J Med. 2004 Oct 7;351(15):1502-12
references.pmid: 15470213
references.citation: Cancer Res. 2008 Aug 1;68(15):6396-406
references.pmid: 18676865
references.citation: J Biol Chem. 2005 Oct 28;280(43):36442-51
references.pmid: 16055444
references.citation: Prostate. 2011 Aug 1;71(11):1139-50
references.pmid: 21656824
references.citation: Carcinogenesis. 2006 Jan;27(1):1-22
references.pmid: 16195239
references.citation: Biochim Biophys Acta. 2011 Aug;1816(1):25-37
references.pmid: 21396984
references.citation: Clin Cancer Res. 2002 Sep;8(9):2912-23
references.pmid: 12231536
references.citation: BMC Cancer. 2006 May 02;6:112
references.pmid: 16670021
references.citation: Am J Transl Res. 2009 Apr 20;1(3):235-48
references.pmid: 19956434
references.citation: Mol Cell Endocrinol. 2012 May 6;354(1-2):63-73
references.pmid: 21914459
references.citation: Cancer Res. 1996 Sep 15;56(18):4096-102
references.pmid: 8797572
references.citation: Cancer Cell. 2003 Sep;4(3):209-21
references.pmid: 14522255
references.citation: Mol Med Rep. 2012 Nov;6(5):955-60
references.pmid: 22895682
references.citation: Oncotarget. 2013 Jan;4(1):106-17
references.pmid: 23362217
references.citation: Mol Endocrinol. 2012 Oct;26(10):1707-15
references.pmid: 22915828
references.citation: J Natl Cancer Inst. 1999 Dec 1;91(23):2038-44
references.pmid: 10580030
references.citation: Int J Cancer. 2006 May 1;118(9):2123-31
references.pmid: 16331600
references.citation: Ann Oncol. 2007 Oct;18(10):1605-19
references.pmid: 17355951
references.citation: Cancer Causes Control. 2001 Aug;12(6):557-67
references.pmid: 11519764
references.citation: Lab Invest. 1998 Jun;78(6):i-xv
references.pmid: 9645768
references.citation: Br J Cancer. 2009 Nov 17;101(10):1740-8
references.pmid: 19844236
references.citation: Carcinogenesis. 2002 Mar;23(3):463-7
references.pmid: 11895861
references.citation: Prostate Cancer Prostatic Dis. 1999 Mar;2(2):70-75
references.pmid: 12496841
references.citation: PLoS One. 2012;7(2):e31919
references.pmid: 22384099
references.citation: Am J Pathol. 2010 Dec;177(6):3180-91
references.pmid: 21088217
references.citation: J Urol. 2012 Apr;187(4):1336-40
references.pmid: 22342512
references.citation: Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7841-6
references.pmid: 12799464
references.citation: Prostate. 2013 Mar;73(4):363-75
references.pmid: 22911278
references.citation: J Cell Physiol. 2010 Sep;224(3):626-35
references.pmid: 20578239
references.citation: Cancer Res. 2001 Jun 15;61(12):4693-700
references.pmid: 11406539
references.citation: Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):532-7
references.pmid: 17372249
references.citation: Cancer Res. 2012 Sep 15;72(18):4765-76
references.pmid: 22836754
references.citation: Cancer Res. 2009 Oct 1;69(19):7696-703
references.pmid: 19773444
references.citation: Oncol Lett. 2012 May;3(5):1166-1170
references.pmid: 22783412
references.citation: J Mol Med (Berl). 2013 Jan;91(1):103-15
references.pmid: 22903544
references.citation: J Immunother. 2010 Jul-Aug;33(6):639-47
references.pmid: 20551832
references.citation: Cancer Res. 1997 Nov 1;57(21):4687-91
references.pmid: 9354422
references.citation: Chin Clin Oncol. 2013 Mar 1;2(1):
references.pmid: 24324949
references.citation: J Mol Endocrinol. 2012 Sep 05;49(2):153-63
references.pmid: 22872134
references.citation: Cancer Lett. 1999 Sep 1;143(2):217-21
references.pmid: 10503907
references.citation: Nat Rev Cancer. 2001 Oct;1(1):34-45
references.pmid: 11900250
references.citation: Ann Nutr Metab. 2009;55(1-3):140-61
references.pmid: 19752540
references.citation: Gut. 1992 Jul;33(7):1006-7
references.pmid: 1353741